Sastasundar Ventures Ltd

Health X Platform Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter ended June 30, 2026. The specific date for the board meeting to consider these results will be communicated separately. This measure is standard practice to prevent potential insider trading.

Health X Platform Ltd announced that its Board of Directors has approved a Composite Scheme of Arrangement and Amalgamation involving Health X Platform Limited, Microsec Resources Private Limited, Innogrow Technologies Limited, and Sastasundar Healthbuddy Limited. The scheme aims to amalgamate these entities, with specific share entitlement and exchange ratios defined for the demerged, resulting, and transferee companies. The appointed date is set for April 1, 2026, with the effective date contingent on regulatory approvals, including from SEBI, NCLT, and stock exchanges. This significant corporate restructuring is subject to various statutory and shareholder approvals.

Health X Platform Ltd announced that its Board of Directors has approved a Composite Scheme of Arrangement and Amalgamation involving Health X Platform Limited, Microsec Resources Private Limited, Innogrow Technologies Limited, and Sastasundar Healthbuddy Limited. The scheme aims to amalgamate these entities, with specific share entitlement and exchange ratios defined for the resulting share issuance. The appointed date for the scheme is set as April 1, 2026, with the effective date contingent on regulatory approvals and filings. The scheme is subject to approvals from stock exchanges, SEBI, NCLT, RBI, and shareholders/creditors.

Health X Platform Ltd announced that its promoter, Mr. Ravi Kant Sharma, has sold 2,50,000 equity shares of the company. The transaction, valued at approximately ₹7.5 crore, occurred on June 3, 2026, via the open market. Following this sale, Mr. Sharma's shareholding in the company has reduced from 3.14% to 2.35%. This disclosure is made in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Health X Platform Ltd, formerly known as Sastasundar Ventures Limited, has officially updated its corporate website to https://www.healthxplatform.com. This change follows the company's recent name change and is in compliance with SEBI (LODR) regulations.

Health X Platform Ltd's board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board also re-appointed M/s. Priya Gupta & Co. as the Internal Auditor for the financial year 2026-27. The meeting concluded on May 30, 2026.

Health X Platform Ltd (formerly Sastasundar Ventures Limited) has announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board of directors approved the results at its meeting on May 30, 2026. M/s. Priya Gupta & Co., Chartered Accountants, were re-appointed as the Internal Auditor for the Financial Year 2026-27. The statutory auditors, M/s JKVS & Co, Chartered Accountants, provided an unmodified opinion on the standalone and consolidated audited financial results.

Health X Platform Ltd has announced a Board of Directors meeting scheduled for May 30, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The trading window for dealing in the company's securities will remain closed until 48 hours after the declaration of the financial results.

Mitsubishi Corporation completed the sale of its entire 4.68% equity stake (10,13,766 shares) in Sastasundar Healthbuddy Limited, a material subsidiary of Health X Platform Ltd, to Envision India Fund on May 12, 2026. Consequently, Mitsubishi Corporation is no longer a shareholder of Sastasundar Healthbuddy Limited. The board of directors of Sastasundar Healthbuddy Limited acknowledged the transfer on May 15, 2026.

Sastasundar Ventures Ltd has received approval from BSE and NSE to change its name to Health X Platform Limited, effective April 30, 2026. The company's stock symbol will also change from SASTASUNDR to HEALTHX. This follows the Certificate of Incorporation pursuant to Change of Name issued by the Registrar of Companies/Ministry of Corporate Affairs.